Choice of release strategy is the first determinant of glycan profiling accuracy. While enzymatic releases maintain sugar integrity, their utility is sequence-dependent. In contrast, chemical releases can uncover a broad range of O-glycans, but suffer from alkaline trimming. Tailoring the release chemistry to the investigative query will allow one to be confident that the observed glyco-signature represents in vivo conditions.
A key aspect to consider when analyzing glycans is how you release glycans from your protein of interest as this will impact what quantity and quality of glycans you will detect during the profiling step. Release methods can cause chemical degradation, incomplete release, or modification of glycans. These artifacts created during release can make interpretation of what glycans are actually biological significant very difficult. Also, keep in mind that N-glycans and O-glycans have distinct core structures which usually require different experimental approaches to successfully analyze. Ideally, your chosen glycan release methods and analysis should be able to detect the largest variety of glycans that make up your glycome of interest while preserving any labile modifications that may be biologically significant.
Fig. 1 N-glycan profiling of a glycoprotein mixture.1,5
The backbone structure of N-glycans and O-glycans are distinct. N-glycans have a core pentasaccharide structure consisting of two N-acetylglucosamines and three mannoses. This pentasaccharide then diverges into high mannose, hybrid or complex types of N-glycans with differing branches and end sugars. Due to this relative similarity in core structures, N-glycans can enzymatically be released by the use of specific amidas that target the glycosylamine bond between the sugar chain and the protein. O-glycans on the other hand vary greatly in their structures. Starting with an N-acetylgalactosamine bound to serine or threonine, there is no common core structure or consensus sequence for O-glycans like there is for N-glycans. This diverse structure and lack of specific endoglycosidases has lead to chemical release of glycans.
Methods used for release of glycans from proteins will affect the purity of the glycan population used for further analysis. Glycans released by enzymatic cleavage using peptide-N-glycosidase F retain the carbohydrate structure but change the attachment site from asparagine to aspartic acid. Peptide-N-glycosidase F releases glycans cleanly with yields suitable for detection. Glycans released by chemical methods including β-elimination release glycans under basic conditions and can lead to peptide or oligosaccharide chain degradation. Artifacts can be formed by continued removal of reducing end residues, also known as peeling reactions. Non-reductive chemical release is labeling compatible but may also lead to degradation if not fully optimized. Release methods will affect observed abundance of glycans on MS and HPLC due to differences in losses of isomers during sample preparation.
Table 1 Influence of Release Method on Analytical Integrity
| Release Approach | Structural Preservation | Potential Artifacts | Compatibility with Labeling |
| Enzymatic digestion | High integrity maintained | Minimal | Compatible with reductive amination |
| Reductive elimination | Core structures preserved | Alditol formation prevents labeling | Limited to specific detection methods |
| Non-reductive chemical | Moderate preservation risk | Peeling products possible | Compatible with fluorescence labeling |
When selecting a release method, consider factors such as sample type, what classes of glycans are present, and what analysis will be performed downstream. Enzymatic release methods are more uniform and standardized for release and can be easily reproduced. These methods are useful when working with purified glycoproteins or monoclonal antibodies since N-glycans are typically the most abundant glycans on those molecules. Enzymatic release methods can also be coupled with chemical release methods to fully cover glycans from complex samples like tissue or serum. If studying O-glycans specifically, chemical release methods must be used. If labeling is required downstream, the chemical release method hydrazinolysis can be used. If maintaining linkage information is desired, release using ammonia β-elimination is useful. Finally, consider what analysis will be performed downstream. Are native structures needed, or can glycans be released as reduced alditols? These decisions can help determine what release method should be used.
Detachment of glycans from proteins is generally considered necessary for most detailed analyses of carbohydrates. Release methods will vary depending on whether they are N- or O-linked glycans. Since N-linked glycans attach to the asparagine residue of the consensus sequence Asn-X-Ser/Thr where X can be any amino acid except proline, they can usually be released enzymatically through treatment with an amidase which will cleave the glycosylamine linkage and little else under fairly mild conditions. O-linked glycans attach to serine or threonine residues and lack any sort of consensus sequence. Chemical methods such as beta-elimination or hydrazinolysis are used to release them.
Chemical and enzymatic releases are at opposite extremes. Enzymatic releases rely on cleaving glycans with glycosidases that hydrolyze specific linkages under mild conditions (generally physiological or near physiological pH and temperature). These methods generally have excellent specificity, but are restricted by the availability of enzymes with specificity for certain glycosidic linkages that do not modify the carbohydrate structure. Chemical releases are non-specific but often require harsh reaction conditions that can destroy labile chemical modifications. Compatibility with downstream analytical methods must also be considered.
Advantages of each release method must be weighed against disadvantages and limitations, as they impact their usefulness. Cleavage methods using enzymes are highly selective for maintaining sensitive structural elements and reproducible release with less formation of artifactual molecules, but they are limited by glycosidic linkage specificity and inability to release some modified glycans. Chemical release methods are less limited in the types of glycans they can release and are not dependent on enzyme availability, but can result in side reactions such as peeling and chemical artifacts that may hinder analysis. The choice of method should be carefully considered based on coverage needed and structural integrity required for compatibility with detection methods.
Release methods can create biases that impact downstream analysis. Inefficient release will leave glycans attached to proteins, causing an underrepresentation of certain glycoforms. Release efficiency may also vary between glycans of different structure, creating a distribution that does not accurately reflect the original species population. Labile glycans like sialic acids and sulfate can be cleaved off during chemical release methods. Peeling reactions that occur under basic conditions will create shortened glycans that are not representative of the original structures. Different classes of glycans may have different efficiencies in derivatization reactions after release. These differences can lead to biases in quantitation when comparing responses between glycans of different classes, samples, or experiments.
Deglycosylation by enzymes is usually the method of choice when isolating N-glycans intact and in their entirety. Peptide-N-glycosidases cleave the bond linking the asparagine residue and the N-acetylglucosamine residue at the root of the N-glycan. Deglycosylation can therefore be quantitative allowing unmodified glycans to be analyzed using sensitive detection methods. Factors that affect the enzyme specificity must be optimized as well as the sample preparation parameters. A side reaction that occurs is the deamidation of asparagine residues which modifies the protein as it cleaves off the glycan.
PNGase F cleaves the glycosidic bond by deamidating the asparagine residue resulting in intact glycans with free reducing ends which can be fluorescently labeled for analysis or used directly in mass spectrometry. PNGase F has fairly broad specificity towards high mannose, hybrid and complex glycans, but can struggle with sterically hindered substrates and some core modifications. PNGase F will not cleave glycans with an α-1,3 linked core fucose residue that are present on plants and invertebrates. For complete analysis, alternate methods must be used to account for these glycans.
PNGase A can be used in complement to PNGase F. PNGase A will cleave those substrates which are α-1,3-core-fucosylated, allowing for the study of glycoproteins from plants or invertebrates. PNGase A has lower activity on glycans containing sialic acid or larger branches. Endo H and Endo F are endoglycosidases which release N-glycans by cleaving within the chitobiose core, however they produce a truncated glycan without the reducing end glucose.
The sample matrix should be pretreated if necessary to facilitate access to glycans and/or allow maximal enzymatic activity. For example, denaturing the protein by heat or the use of surfactants can help expose glycosylation sites that are hidden by the protein's tertiary structure. Reaction conditions should also be chosen carefully to facilitate enzyme activity. For example, working at a neutral or slightly basic pH will help enzyme activity. Excessive amounts of chaotropes or detergents can often interfere with enzymatic activity. Dialysis or precipitation to remove salts, nucleophiles or other proteins is often carried out prior to enzymatic digestion.
Release by enzymatic hydrolysis also changes asparagine residues into aspartic acid, which can be detected by the shift in mass of about 1 dalton and can serve as an indicator that a protein was glycosylated at that location. The shift from asparagine to aspartic acid can also change the charge of the protein and therefore may alter both isoelectric focusing and migration on gels. Additionally, when looking at the protein component of a glycosylated protein it must be kept in mind that the aspartic acid residues formed upon deglycosylation may affect downstream digestion or epitope recognition.
Chemical release methods of N-glycans can be used when enzymatic release is not possible. The most common methods use harsh conditions to break the glycosylamine linkage non-enzymatically. These methods involve either acids to cleave the glycosidic linkage by acid hydrolysis or oxidizing agents to break down the protein while leaving the carbohydrate intact. Chemical release methods are not limited by enzyme specificity and can be used on any sample type; however, they also increase the possibility for degradation of structures and must be optimized to ensure complete release with minimal destruction of labile modifications.
Fig. 2 Sample preparation for N-glycan analysis by LC-MS/MS.2,5
The acidic release method utilizes low pH conditions to protonate the glycosylamine nitrogen resulting in hydrolysis of the N-glycosidic linkage. This releases intact oligosaccharides from their protein substrates. Agents typically used include trifluoroacetic acid and formic acid. Conditions are adjusted such that the desired level of cleavage occurs before significant degradation of the oligosaccharides. Oxidative release agents such as sodium hypochlorite break peptide linkages while leaving glycans intact. These release agents simultaneously deglycosylate proteins and degrade them. Chemical release methods can be used on samples that are not amenable to enzymatic release or are known to contain inhibitors of the enzymes needed for glycan release. Reaction conditions must be carefully controlled to prevent loss of carbohydrate material.
Chemical release is not dependent on enzyme availability but can be used on samples with protease inhibitors or denaturing agents present that inhibit enzymatic release. Chemical release can also completely destroy the protein, making further purification easier if desired. Drawbacks to chemical release include glycan structural alterations due to acid hydrolysis of glycosidic linkages, sialic acid degradation under extreme pH conditions, low release efficiency from extremely glycosylated proteins, and the conditions necessary to chemically cleave glycans often destroy the structural integrity of acid labile modifications causing artifactual peaks to appear.
Release methods that use chemicals may be desired when the samples include strong inhibitors of enzymes, when protein degradation is needed simultaneously with release for easier downstream purification, or when samples are from organisms which contain glycans that are not cleaved by known glycosidases. Chemical release methods may be needed if samples are derived from plants with β-1,2-xylose or α-1,3-fucose on glycans as core modifications because PNGase F cannot be used. Tissue samples that are extensively cross-linked or fixed typically cannot be digested well enzymatically, so chemicals may work better to release glycans.
Release techniques refer to methods for releasing O-glycans from proteins. Because there are no enzymes with universal specificity for cleaving O-glycosidic bonds on various substrates found in nature, chemical methods are the most common release techniques. The most common release technique is alkaline β-elimination. In this method, the glycosidic bond linking serine/threonine side chains to the terminal N-acetylgalactosamine moiety is labile under basic conditions. The chemical release of O-glycans also allows for varying structures of glycans released.
Reductive β-elimination proceeds via base-catalyzed cleavage of the O-glycosidic linkage between the serine or threonine residue and the glycan, followed by reduction of the resulting glycan aldehyde to an alditol. Deprotonation and peptide-catalyzed elimination of the glycosidic bond is favored in an alkaline environment such as sodium or potassium hydroxide at high temperature. Borohydride reagents are used to trap the reactive aldehyde intermediate by reduction to a stable alditol prior to subsequent recondensation or degradation reactions. The carbohydrate products are readily analyzed directly or can be fluorescently labeled after reductive β elimination but cannot be further derivatized at the reducing end.
Secondary degradation pathways called peeling reactions become active under the extreme pH conditions used for β-elimination. In these reactions carbohydrates are sequentially eliminated from the reducing end upon extended treatment with base. Each step of this peeling process further degrades the glycan by β-elimination of a substituted hydroxyl group. Shorter oligosaccharides are the artifacts produced by this process that can mask true composition. Peeling of sialic acid residues will also occur upon extended exposure to high pH conditions. Sialic acid residues can often be lost from glycans as intact monosaccharides or be modified by base.
Peeling can be minimized by alteration of reaction conditions or addition of protective chemistries during chemical release of O-glycans. Protective deoxidization of released sugars is achieved through inclusion of reducing agents, which trap the released aldehydes as inert alditols before they can participate in further reactions leading to peeling. Alternative chemistries accomplish non-reductive protection from peeling by trapping intermediates formed during release under milder basic conditions followed by fluorescent tagging; these methods are complicated by incomplete quantitative recovery of labeled sugars. Reaction conditions can also be tuned through addition of chaotropic salts or organic cosolvents to slow release reactions down.
Two classes of enzyme-based methods for O-glycan release have recently become available. Their development reflects the lack of broadly reactive O-glycanases like PNGase F described above. These newer methods include: O-glycosidases with specificities for known core structures, O-glycoproteases that cleave the peptide backbone while leaving glycans intact, and chemoenzymatic methods that use more than one selective method to overcome the limitations of each. Many of these methods are more benign than chemical β-elimination, allowing for detection of labile modifications while still liberating glycans from the protein efficiently. However, the substrate specificities of these enzymes currently cover a smaller range of potential glycans than available N-glycan releasing enzymes.
Endo-α-N-acetylgalactosaminidases (O-glycosidases) have limited substrate specificities, acting only on Core 1 disaccharides of galactose β-1,3-linked to N-acetylgalactosamine on serine or threonine. Some act on Core 3 structures as well, with N-acetylglucosamine replacing galactose. They are unable to cleave sugars with extensions beyond the disaccharide Core such as sialic acid capping, fucosylation, or additional antennae. As such Core releasing endoglycosidases require prior treatment with exoglycosidases to remove peripheral sugars, before they are able to release the core sugars.
Approaches utilizing enzymes for O-glycan release are limited by narrow substrate specificities that exclude many longer or sialylated O-glycans common in mammalian cells. Sequential incubation with different exoglycosidases to reveal underlying core structures also requires additional sample processing steps that can destroy labile modifications and lead to poor quantitative yields. Enzymatic methods will also typically only release glycans containing short disaccharide core structures, cleaving off more complex glycans instead of releasing them intact. Because of this, only the simplest glycans can be structurally analyzed using enzymatic release methods preventing characterization of biologically relevant glycans containing antennae or complex capping groups.
Yet another approach is a hybrid between enzymatic and mild chemical release. Both methods are desirable because enzymes like glycosidases have specific recognition and activity profiles while chemical release often results in more complete release and/or cleavage of a wider range of structures. Sequential workflows may involve the use of sialidases or other exoglycosidases to remove terminal modifications, followed by enzymatic release or mild chemical release to release any remaining core structures. Another option is a chemoenzymatic release protocol, in which selective digestion of glycans by enzymes is combined with mild β-elimination conditions that reduce peeling side reactions.
Release strategies can be compared based on the number/types of glycans they target, their effect on glycan modifications, and how amenable the released glycans are to further analysis. Enzymatic and chemical releases each have their advantages and disadvantages depending on the goals of analysis. The enzymatic release of N-linked glycans is routine and often preferred due to the availability of peptide-N-glycosidases which exhibit high specificity and cause little modification to the glycans. However, since no broad specificity enzymes are available for O-linked glycans, release is usually performed chemically via β-elimination or hydrazinolysis. Familiarity with the pros and cons of each release strategy will help analysts choose an approach that best suits their needs balancing type of glycan targeted versus modifications preserved.
There are differences in release efficiencies between enzyme- and chemical-based releases. For example, PNGase F release of N-glycans from glycoproteins is nearly quantitative for mammalian proteins but it will not release glycans from core-fucosylated plant glycans. Chemically induced release such as hydrazinolysis works for a wider range of glycans from various sources, but is often incomplete. Removal of O-glycans via chemical β-elimination is currently the most general approach, although other techniques yield incomplete release. Novel enzymes that release O-glycans after cleaving specific cores provide a much gentler release, but have a limited range of substrates.
One major advantage of enzymatic methods over chemical methods is structural preservation of labile glycans. Methods that use reagents such as hydrazine are usually milder and preserve modifications such as sialic acids, sulfates and acetyl groups. Chemical release by reductive β-elimination results in stable alditols that cannot participate in peeling reactions, but they also cannot be fluorescently labeled in subsequent reactions that require reducing-end aldehydes. While hydrazinolysis leaves reducing ends available for derivatization, the longer the hydrolysate is exposed to hydrazine, the more chance there is of degradation of labile post-translational modifications. Because β-elimination requires strong alkaline conditions, there is always a possibility of epimerization or de-O-acetylation reactions occurring unless the reaction time is optimized to minimize disruption while still allowing efficient release.
Compatibility with downstream applications is also an important consideration when choosing a method. Glycans released enzymatically are compatible with labeling methods for fluorescence detection, mass spectrometry, and chromatography because no excess reagents are released in the reaction. Reductive β-elimination restricts compatible detection methods to mass spectrometry or NMR since the liberated sugars are converted to alditols which are not amenable to reductive amination labeling. Labeling is possible with glycans liberated by non-reductive chemical methods but the excess salt byproducts can complicate downstream processing. Harsh reaction conditions associated with hydrazinolysis require extensive clean-up prior to analysis by chromatography or electrophoresis.
The choice of glycan release method has major consequences on both the quantitative and qualitative results obtained during glycomic analysis. As such different release methods can introduce biases in measured relative abundances of glycans as well as affecting glycan structure determination. Release methods may be biased towards certain classes of glycans or glycan structures resulting in incomplete release of all glycoforms present. Chemical conditions used during release can also alter glycan structures through chemical modification leading to artefacts such as peeling reactions, desialylation and epimerisation.
When relative quantification is desired, the choice of release method biases quantification considerably. This is due to incomplete cleavage of some glycoforms over others during enzymatic release. Some enzymes have preferences for certain glycans leaving others uncleaved. Chemical release will also cleave preferentially depending on molecular size, charge, and accessibility. Some glycans may not release as readily as others due to these factors which can result in less glycan detected. Therefore, peak areas will not represent the true relative quantities.
Method of release also determines downstream compatibility with labeling chemistry since the reducing terminus can be chemically altered upon release. Reduction β-elimination permanently alters the reducing ends to an alditol form that will not accept labeling through reductive amination methods since the free aldehyde group has been removed. Enzymatic release methods retain the reducing aldehyde group allowing for broader downstream derivatization options such as reductive amination with fluorophores or isobaric mass tags. Salt or reaction byproducts from chemical releases can also negatively impact chromatography or labeling efficiency. Additional purification may be necessary, running the risk of sample loss and affecting quantitative recovery.
Table 2 Impact of Release Methods on Labeling Compatibility
| Release Approach | Reducing End State | Labeling Compatibility | Purification Requirement |
| Enzymatic | Intact aldehyde | Full compatibility with reductive amination | Minimal cleanup needed |
| Reductive chemical | Alditol formation | Limited to mass spectrometry methods | Desalting recommended |
| Non-reductive chemical | Intact with contaminants | Compatible but requires cleanup | Extensive purification |
Reproducibility is also dependent on the release strategy employed. Release efficiency can vary due to kinetics, matrix effects and the sensitivity to processing variables. Proteinase-mediated release usually has the best reproducibility when normalized to protein content, buffer and incubation conditions; however, variability in enzyme activity between lots should be considered. Chemical release is more difficult to reproduce as slight changes in temperature and reagent quality can alter release efficiency. Additionally, incomplete release or overdigestion can occur, leading to protein degradation. Optimization with quality control samples and tracking of technical replicates with statistical quality control will ensure a robust method.
Choice of glycan release method must take into account many practical considerations such as sample matrix and desired throughput along with application. Sample matrix varies greatly from pure proteins of interest such as monoclonal antibodies to complex tissue digests. Monoclonal antibodies allow the greatest flexibility in release method since glycan sites are readily accessible and matrix interference is minimal. Analytical questions also affect release strategy as some methods provide more detailed structural information than others. Pure research applications tend to prioritize obtaining as much structural information as possible while quality control applications focus on generating consistent data in a high-throughput fashion. Details like these and others will affect automation capabilities and scalability of selected methods.
Considerations regarding sample composition will impact the choice of release strategy. Accessibility of glycosylation sites and presence of interfering components may vary by sample matrix. If working with purified antibodies or protein drug substance, enzymatic release conditions may be easily standardized to allow for consistent digestion. Samples with more complex composition (e.g., serum, tissue homogenates, or cell lysates) may need additional sample preparation such as protein denaturation or disruption with detergent, or removal of interfering components prior to enzymatic release. Any interfering components in the sample can also affect enzyme activity or chemical reaction rates. Optimization of each method will be required to sample matrix to achieve complete deglycosylation without impacting overall glycan integrity or causing artifacts.
Consideration of throughput requirements early in the process can help to inform the decision of which release strategy to use. For larger scale applications requiring higher throughput enzymatic release reactions are much easier to scale up by the utilization of temperature incubations with minimal user intervention allowing up to 96 samples to be released in a matter of hours. Ease of scalability of chemical release reactions is limited by hazardous reagent manipulation and clean-up steps. However, platforms for medium throughput release reactions have been established utilizing chemical release reactions followed by automated desalting and labeling clean-up steps. Procedures used should be scalable with project growth from manual techniques to semi-automated procedures and fully robotic procedures.
The intended use of the glycan release procedure will influence which type of procedure is used. In discovery applications where extensive coverage and structural information are desired regardless of experimental complexity or throughput, chemical release methods may be desirable. If glycan analysis will be used for process development and biopharmaceutical manufacturing, a method with validated, repeatable results will be necessary. Methods that have been used extensively throughout the development and manufacture of glycoproteins and that have proven robust performance characteristics are enzymatic release methods. Finally, in quality control applications where high throughput and ruggedness are key considerations, some of the more streamlined enzymatic release methods which incorporate automated steps may be ideal.
Methods of glycan release often suffer from incomplete recovery and structural degradation of glycans. Each release method has its own unique biases, which alters the resulting composition of the glycome that is analyzed. The biggest drawback of glycan release techniques are rooted in the difficulty to release all classes of glycans while maintaining their native structures intact. Limitations of each release technique should be considered when analyzing glycomic data. Care should be taken when choosing a release method that will yield the least amount of artifacts and allow for analysis of as many biologically significant carbohydrates as possible.
Retention can result in incomplete release where glycans are left behind on the protein carrier due to steric hindrance, inhibitor presence or incomplete cleavage reactions. This phenomenon causes underrepresentation of certain glycoforms in the measured distribution. Loss of material can happen during various stages of sample handling such as non-specific adsorption to solid phases during purification or washing steps, co-precipitation with proteins or poor recovery during desalting columns. These losses can affect certain glycan populations or molecular weight ranges differentially, leading to quantitative artifacts in glycoform abundances.
Methods that rely on chemical release result in artifacts that include degradation reactions such as peeling reactions, in which reducing-end monosaccharides are progressively lost under alkaline conditions, leading to shorter glycans than were present on the protein. Degradation can also result from base-catalyzed de-N-acetylation of amino sugars or removal of O-acetyl groups from sialic acids. All of these reactions lead to artifacts that are observed in both chromatographic peaks and mass spectral interpretations.
Table 3 Chemical Artifacts and Their Manifestations
| Artifact Type | Chemical Process | Manifestation in Analysis |
| Peeling degradation | Base-catalyzed elimination from reducing end | Truncated glycan peaks |
| Deacetylation | Alkaline hydrolysis of N-acetyl groups | Mass shifts and altered retention |
| Side product formation | Incomplete reaction or rearrangement | Unexpected chromatographic peaks |
There are always compromises made when choosing a release strategy. Enzymatic release maintains labile modifications but is limited by the glycan class and linkage-specificity of enzymes, and will not be comprehensive for glycans containing non-canonical structures or sterically hindered linkages. Chemical releases have broad specificity, but reaction conditions often damage labile modifications. Non-reductive releases allow for fluorescent labeling of glycans post-release, while released glycans treated with reductive methods are unable to be fluorescently labeled due to destruction of the aldehyde group, but are less susceptible to unwanted peeling. Selecting an appropriate release method requires consideration of these factors with the needs of the analysis and population of glycans of interest.
Release conditions can have profound effects on carbohydrate analysis workflows and outcomes downstream. As such, choosing a release method is critically important and should consider both the strengths and limitations of each method and how those align with what needs to be analyzed. Decisions may range from methods that aim to maximize coverage of the entire glycome versus those that may preserve structure better for biological interpretation. Release methods must also take into account sample quantity, experimental throughput, and available resources. Overall, enzymatic methods tend to be best for release of N-glycans, but are less useful for O-glycans. Chemical release strategies tend to be more universal; however, they often do not preserve the structure of glycans as well. When choosing a method for release, it is important to remember that there is no one-size-fits-all approach. Consideration should be given to the glycan population of interest, what workflows will be used downstream, and what the goal of the experiment is. These factors will help ensure that the released carbohydrates are as biologically meaningful as the native structures on the protein.
Accurate glycan profiling begins with efficient and well-controlled glycan release. Incomplete release, structural degradation, or chemical artifacts at this early stage can compromise downstream quantification and structural interpretation. Our glycan release and profiling services are designed to ensure high recovery, structural integrity, and compatibility with advanced analytical platforms, including HPLC and LC-MS. By combining enzymatic and chemical release strategies with optimized downstream workflows, we provide reliable N-glycan and O-glycan analysis for research, biopharmaceutical development, and quality control applications.
Different glycan classes and sample matrices require different release strategies. We select and optimize release conditions based on:
For N-glycan release, we apply enzymatic approaches such as PNGase F or PNGase A under controlled conditions to maximize efficiency while minimizing deamidation artifacts. When enzymatic release is unsuitable, carefully validated chemical approaches may be used. For O-glycan release, where no universal enzyme exists, we implement optimized chemical methods such as reductive β-elimination while controlling reaction parameters to reduce peeling and degradation. Each protocol is validated for release completeness, reproducibility, and compatibility with quantitative glycan profiling workflows.
Glycan release is only one component of a reliable glycomics workflow. We integrate release strategies with:
By aligning release chemistry with downstream analytical objectives, we minimize bias and ensure that glycan distributions accurately reflect the original biological sample. This integrated approach supports applications ranging from early research studies to biopharmaceutical comparability and regulatory-facing analyses.
If you require optimized N-glycan or O-glycan release strategies for accurate glycan profiling, our team provides customized, quality-controlled solutions tailored to your sample type and analytical goals.
Contact us to discuss your project requirements, downstream analysis needs, and timeline for comprehensive glycan characterization.
References
